Saturday, 13 February 2016

Transcription

1 Saturday, 13 February Opening and welcome C.R. Chapple, Sheffield (GB) What is new in urology 1 Chairs: C. R. Chapple, Sheffield (GB) Functional urology C. Gratzke, Munich (DE) What s new in renal cancer Recent developments in BPH O. Reich, Munich (DE) What is new in endourology? A. Patel, London (GB) Localised prostate cancer Coffee break What is new in urology 2 Chairs: F. Montorsi, Milan (IT) Advanced prostate cancer Bladder cancer Reconstructive urology H. Hashim, Bristol (GB) Screening and treating prostate cancer M. Roupret, Paris (FR) Welcome cocktail

2 Sunday, 14 February An update on medical urology for the urooncologist Chair: Coffee break Evolution of PSA and biomarkers for prostate cancer Avoiding unnecessary radical prostatectomy M. Wirth, Dresden (DE) What s new in ablation therapy of prostate cancer? Urological challenge Critique panel: W. Aulitzky, Vienna (AT),, C. Gratzke, Munich (DE),, Ablative surgery for benign prostatic obstruction relief: Which technique for which patient? J.N. Cornu, Paris (FR) Current and future directions in the management of recurrent urinary tract infections B. Köves, Budapest (HU) Reporting complications after urologic procedures is the Clavien system a sufficient concept? Video session Paediatric urology update and case discussion Chair: J.M. Nijman, Groningen (NL) Functional urology cases Chairs: P. Abrams, Bristol (GB) C. R. Chapple, Sheffield (GB) Coffee break Hands-on training on URS Tutors: J-T. Klein, Ulm (DE) Urological challenge Critique panel: P. Abrams, Bristol (GB), H. Hashim, Bristol (GB), T. Knoll, Sindelfingen (DE), O. Reich, Munich (DE), M. Roupret, Paris (FR)

3 Sentinel lymph node dissection in prostate cancer Do we observe a gradual decline in the importance of standard TURBT? A. Czech, Cracow (PL) Monday, 15 February Update on bladder cancer management Chair: Coffee break What are we doing wrong M. Roupret, Paris (FR) Any new evidence in the last 10 years in bladder cancer? The future in bladder cancer Urological challenge Critique panel: W. Aulitzky, Vienna (AT), M. Nijman, Groningen (NL), A. Patel, London (GB), O. Reich, Munich (DE), H. Van Poppel, Leuven (BE) Laparoscopic artificial urinary sphincter implantation A. Czech, Cracow (PL) Prostate biopsy in the era of multiresistant infections should we change practice? B. Köves, Budapest (HU) The role of chemotherapy and androgen deprivation therapy in first-line treatment of prostate cancer Video session Open oncological surgery tips and tricks Chair: M. Wirth, Dresden (DE) Prostatectomy Cystectomy Nephronsparing H. Van Poppel, Leuven (BE) Translational research in urology Chair: H.G. Van Der Poel, Amsterdam (NL) Clonal origin of metastases and treatment options Androgen receptor, new insights H.G. Van Der Poel, Amsterdam (NL)

4 New immunotherapy options Recent developments in stone therapy Chair: Lasers for stones - New aspects for an aging concept ESWL - The new phoenix? Has URS reached the sky? Hands-on training on URS Tutors: J-T. Klein, Ulm (DE) Coffee break Urological Challenge Critique panel: M. Roupret, Paris (FR),, J. Rassweiler, Heilbronn (DE),, H.G. Van Der Poel, Amsterdam (NL), Image-fusion based prostate biopsy comparison of different devices und techniques Defining the role of male slings for post-prostatectomy incontinence management J.N. Cornu, Paris (FR) Tuesday, 16 February The future of translational research and collaboration between urologists and industry H. Van Der Poel, Amsterdam (NL) What s new in andrology 2015? W. Aulitzky, Vienna (AT) Coffee break Bipolar enucleation T. Herrmann, Hannover (DE) Urological challenge Critique panel: C.R. Chapple, Sheffield (GB), H. Hashim, Bristol (GB), A. Patel, London (GB), H. Van Poppel, Leuven (BE), M. Wirth, Dresden (DE)

5 Regenerative therapy of the urinary sphincter: Myth or reality? J.N. Cornu, Paris (FR) Salvage radical prostatectomy following initial active surveillance Evidence-based management of catheter-associated urinary tract infections B. Koves, Budapest (HU) Video session How useful is the robot in contemporary practice? How much is hype? Tips and tricks in functional urology C.R. Chapple, Sheffield (GB) What does the future hold for urology over the next 10 years? Oncology M. Wirth, Dresden (DE) LUTS P. Abrams, Bristol (GB) Andrology F.M.J. Debruyne, Arnhem (NL) Endourology Coffee break Urological challenge Critique panel: P. Abrams, Bristol (GB),, C. Gratzke, Munich (DE), J.M. Nijman, Groningen (NL),, Oncologic and functional outcomes after laparoscopic and robotic-assisted laparoscopic radical prostatectomy Evolution and evaluation of repeat prostate biopsy strategies A.K. Czech, Cracow (PL)

6 Faculty P. Abrams, Bristol (GB) W. Aulitzky, Vienna (AT) C.R. Chapple, Sheffield (GB) F.M.J. Debruyne, Arnhem (NL) C. Gratzke, Munich (DE) H. Hashim, Bristol (GB) F. Montorsi, Milan (IT) J.M. Nijman, Groningen (NL) A. Patel, London (GB) O. Reich, Munich (DE) M. Roupret, Paris (FR) H.G. Van Der Poel, Amsterdam (NL) H. Van Poppel, Leuven (BE) M. Wirth, Dresden (DE) Challengers J.N. Cornu, Paris (FR)F A.K. Czech, Cracow (PL) B. Koves, Budapest (HU) Tutors J-T. Klein, Ulm (DE)